Nuclear matrix associated protein PML: an arsenic trioxide apoptosis therapeutic target protein in HepG2 cells. | Chin Med J (Engl);116(1): 93-8, 2003 Jan. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Nuclear matrix associated protein PML: an arsenic trioxide apoptosis therapeutic target protein in HepG2 cells.

Yu, Ding; Wang, Zihui; Zhu, Liyuan; Chew, E C.

Affiliation

Yu D; Department of Surgery, Shenzhen Hospital, Beijing University, Shenzhen 518036, China.

Chin Med J (Engl) ; 116(1): 93-8, 2003 Jan.

Article in En | MEDLINE | ID: mdl-12667397

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Oxides / Arsenicals / Transcription Factors / Nuclear Proteins / Nuclear Matrix / Neoplasm Proteins / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Chin Med J (Engl) Year: 2003 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Oxides / Arsenicals / Transcription Factors / Nuclear Proteins / Nuclear Matrix / Neoplasm Proteins / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Chin Med J (Engl) Year: 2003 Document type: Article Affiliation country: Country of publication: